Table 2.
Side effects | Pregabalin (n=55) |
Placebo (n=52) |
P-value |
---|---|---|---|
Ever experienced | |||
Nausea | 43 (78.2%) | 42 (80.8%) | 0.74 |
Vomiting | 28 (50.9%) | 30 (58.8%) | 0.41 |
Sleepy | 47 (85.5%) | 39 (76.5%) | 0.24 |
Dizzy | 45 (81.8%) | 26 (50%) | <0.01 |
Headache | 28 (50.9%) | 17 (33.3%) | 0.07 |
Blurred vision | 15 (27.3%) | 7 (13.7%) | 0.09 |
Diarrhea | 28 (50.9%) | 29 (56.9%) | 0.54 |
Constipation | 6 (10.9%) | 15 (29.4%) | <0.02 |
Dry mouth | 22 (40%) | 25 (48.1%) | 0.40 |
After study capsule | |||
Nausea | 37 (67.3%) | 38 (73.1%) | 0.51 |
Vomiting | 20 (36.4%) | 25 (49%) | 0.19 |
Sleepy | 47 (85.5%) | 35 (68.6%) | <0.04 |
Dizzy | 45 (81.8%) | 22 (42.3%) | <0.01 |
Headache | 17 (30.9%) | 15 (29.4%) | 0.87 |
Blurred vision | 15 (27.3%) | 6 (11.8%) | <0.05 |
Diarrhea | 25 (45.5%) | 28 (54.9%) | 0.33 |
Constipation | 5 (9.1%) | 11 (21.6%) | 0.07 |
Dry mouth | 21 (38.2%) | 21 (40.4%) | 0.82 |
Data are n (%).